Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis

Breast Cancer Research and Treatment

Volumn 88, Issue 2, 2004, Pages 109-116

  Lightfoot, Harry M ^a   Lark, Amy ^a   Livasy, Chad A ^a   Moore, Dominic T ^b   Cowan, David ^b   Dressler, Lynn ^b   Craven, Rolf J ^c   Cance, William G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

breast cancer; focal adhesion kinase; immunohistochemistry; protein tyrosine kinases

Indexed keywords

FOCAL ADHESION KINASE;

ARTICLE; BREAST CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL;

BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROCYSTIC BREAST DISEASE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION PROFILING; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; PROTEIN-TYROSINE KINASES; UP-REGULATION;

EID: 9644275426     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-1022-8     Document Type: Article

References (44)

1. American Cancer Society, Inc: Cancer statistics, 2003. Surveillance Research, 2003
2. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002
3. Adeyinka A, Emberley E, Niu Y, Snel L, Murphy LC, Sowter H, Wykoff CC, Harris AL, Watson PH: Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Can Res 8: 3788-3795, 2002
4. Kapucuoglu N, Losi L, Eusebi V: Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive breast carcinomas. Virchows Arch (A) 430: 17-22, 1997
5. Bartkova J, Barnes DM, Millis RR, Gullick WJ: Immunohistochemical demonstration of c-erb-2 protein in mammary ductal carcinoma in situ. Hum Pathol 21: 1164-1167, 1990
6. Moreno A, Figueras A, Lloversa B, Escobedo A, Griera E, Sierra A, Fabra A: Apoptosis in ductal carcinoma in situ of the breast. Breast J 7(4): 245-248, 2001
7. Jeffer S, Bleiweiss IJ: Histologic classification of ductal carcinoma in situ. Microsc Res Technique 59: 92-101, 2002
8. Kausch I, Lingau A, Endl E, Sellmann K, Deinert I, Ratliff TR, Jocham D, Sczakiel G, Gerdes J, Bohle A: Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo. Int J Cancer 105: 710-716, 2003
9. Cary LA, Guan J: Focal adhesion kinase in integrin-mediated signaling. Frontiers Biosci 4: 102-113, 1999
10. Xu L, Owens LV, Sturge G, Yang X, Lui ET, Carven RJ, Cance WG: Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 7: 414-418, 1996
11. Hanks, S, Calalb M, Harper M, Patel S: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Nat Acad Sci USA 89: 8487-8491, 1992
12. Akasaka T, van Leeuwen R, Yoshinaga I, Mihm M, Byers H: Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J Invest Dermatol 105: 104-108, 1995
13. Gates RE, King LE, Hanks SK, Nanney LB: Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ 5: 891-899, 1994
14. Sieg DJ, Hauck CR, Ilic D, Klingbei CK, Schaefer E, Damsky CH, Schlaepfer DD: FAK integrates growth factor and integrin signals to promote cell migration. Nat Cell Bio 2: 249-256, 2000
15. Hauck CR, Sieg DJ, Hsia D, Loftus J, Gaarde W, Monia B, Schlaepfer DD: Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 61: 7079-7090, 2001
16. Matsumoto K, Nakamura T, Kramer R: Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125 FAK) and promotes migration and invasion of oral squamous cell carcinoma cells. J Biol Chem 269: 31807-31813, 1994
17. Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D, Boileau G, Papandreou C, Gancotti F, Knudsen B, Nanus, D.: Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J Clin Invest 106: 1399-1407, 2000
18. Cary L, Chang J, Guan J: Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 140: 211-221, 1996
19. Zhao J, Pestell R, Guan J: Transcriptional activation of Cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Bio Cell 12: 4066-4077, 2001
20. Zhao J, Reiske H, Guan J: Regulation of the cell cycle by focal adhesion kinase. J Biol Chem 143(7): 1997-2008, 1998
21. Reiske HR, Zhao J, Han DC, Cooper LA, Guan J: Analysis of FAK-associated signaling pathways in the regulation of cell cycle progression. FEBS Lett 486: 275-280, 2000
22. Abdel-Ghany M, Cheng H, Elble R, Pauli B: Focal adhesion kinase activated by beta-4 integrin ligation to mCLCA1 mediates early metastatic growth. J Biol Chem 277: 34391-34400, 2001
23. Kanner SB, Reynolds AB, Vines RR, Parsons JT: Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA 87: 3328-3332, 1990
24. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT: pp125fak a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89: 5192-5196, 1992
25. Weine TM, Lui ET, Craven RJ, Cance WG: Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann Surg Oncol 1: 18-27, 1994
26. Weiner TM, Lui ET, Craven RJ, Cance WG: Expression of focal adhesion kinase gene and invasive cancer. Lancet 342: 1024-1025, 1993
27. FAK) in invasive human tumors. Cancer Res 55: 2752-2755, 1995
28. Kornberg LJ: Focal adhesion kinase expression in oral cancers. Head and Neck 20: 634-639, 1998
29. Rovin JD, Frierson HF, Ledinh W, Parsons JT, Adams RB: Expression of focal adhesion kinase in normal and pathologic human prostate tissues. The Prostate 53: 124-132, 2002
30. Judson PL, He X, Cance WG, Van Le L: Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian cancer. Cancer 86: 1551-1556, 1999
31. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L: Immunohistochemical analysis of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Can Res 6: 2417-2423, 2000
32. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C: Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323: 1457-1462, 1990
33. Cowan DW, Dressler LG: Simultaneous evaluation of erbb2 protein expression and gene amplification: a sequential double labeled techniques combining immunohistochemistry and fluorescence in situ hybridization. Breast Cancer Res Treatment 50: 294, 1998
34. Lark AL, Livasy CA, Calvo B, Caskey L, Moore DT, Yang X, Cance WG: Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Can Res 9: 215-222, 2003
35. Oktay MH, Oktay K, Hamele-Bena D, Buyuk A, Koss LG: Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Human Pathol 34(3): 240-245, 2003
36. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544, 1995
37. Owen J, Ruest P, Fry D, Hanks S: Induced focal adhesion kinase expression in FAK null cells enhances cell spreading and migration requiring both auto and activation loop phosphorylation sites and inhibits adhesion dependent tyrosine phosphorylation of Pyk2. Mol Cell Bio 19: 4806-4818, 1999
38. Sieg DJ, Hauck CR, Schlaepfer DD: Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 112: 2677-2691, 1999
39. 2-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res 61: 4978-4981, 2001
40. van de Water B, Houtepen F, Huigsloot M, Tijdens IB: Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LL-PK1) cells by focal adhesion kinase. J Biol Chem 276: 36183-36193, 2001
41. Xu L, Yang X, Bradham CA, Brenner DA, Baldwin AS, Craven RJ, Cance WG: The focal adhesion kinase suppresses transformation associated, anchorage-independent apoptosis in human breast cancer cells. J Biol Chem 275: 30597-30604, 2000
42. Malmusi M, Ackerman AB: Apoptosis is a type of necrosis. Part I: the importance of historical perspective and definition. Dermatopathol Pract Concepts 4: 15-27, 1998
43. Soomro S, Shousha S, Taylor P, Shepard H, Feldman M: c-erb-2 expression in different histological types of invasive breast cancer. J Clin Pathol 44: 211-214, 1991
44. Allred D, Clark G, Molina R, Tandon A, Schnitt S, Gilchrist K, Osborne C, Tormey D, Mcguire W: Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23: 974-979, 1992